32
CENTER FOR VALVE DISORDERS
TAVR cases ( FY20 ):
227
Percutaneous mitral valve procedures since
2011 :
124
Median length
of stay :*
1 day
TAVRs since 2011 :
1,223
Commercial TAVR in-hospital observed
mortality rate :*
0.7 %
Femoral access in
TAVR patients :*
99 %
Minimally invasive mitral valve repair inhospital mortality rate :*
0 %
The Center for Valve Disorders is a high-volume program that expands minimally invasive treatment options for patients with structural heart disease . Therapies available through the Center for Valve Disorders include :
• Minimally invasive aortic , mitral , pulmonic and tricuspid valve repair and replacement
• Transcatheter valve-in-valve implantation for failed bioprosthetic valves in the aortic and mitral position
• MitraClip ® and transcatheter mitral valve repair ( TMVR ) for high surgical risk patients with severe mitral regurgitation
• Balloon mitral valvuloplasty for mitral stenosis
• Percutaneous left atrial appendage occlusion
• Percutaneous patent foramen ovale closure
• Percutaneous atrial septal defect closure
• Alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Advanced imaging capabilities :
• 384-slice CT scanner
• 1.5 Tesla magnetic resonance imager
Baylor Scott & White Heart and Vascular Hospital - Dallas was rated High Performing in Transcatheter Aortic Valve Replacement by U . S . News & World Report for 2020 - 21 .
* STS / ACC TVT Registry Institutional Outcomes Report 2019Q4 R4Q